SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | 0.0% | 10,979 | +33.2% | 0.00% | – |
| Q4 2015 | $3,000 | -84.2% | 8,243 | -23.2% | 0.00% | – |
| Q3 2015 | $19,000 | +171.4% | 10,740 | +223.7% | 0.00% | – |
| Q2 2015 | $7,000 | +75.0% | 3,318 | +67.6% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 1,980 | +4.4% | 0.00% | – |
| Q4 2014 | $5,000 | -16.7% | 1,897 | +3.7% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 1,829 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | -30.0% | 1,829 | -18.3% | 0.00% | – |
| Q1 2014 | $10,000 | -9.1% | 2,238 | +3.1% | 0.00% | – |
| Q4 2013 | $11,000 | -66.7% | 2,171 | -58.6% | 0.00% | – |
| Q3 2013 | $33,000 | +135.7% | 5,240 | +86.1% | 0.00% | – |
| Q2 2013 | $14,000 | – | 2,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |